Rafferty Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.83M | Buy |
21,296
+5,985
| +39% | +$525K | ﹤0.01% | 661 |
|
|
2026
Q1 | $1.38M | Sell |
15,311
-6,028
| -28% | -$553K | 0.01% | 690 |
|
|
2025
Q4 | $1.92M | Sell |
21,339
-658
| -3% | -$62.4K | 0.01% | 655 |
|
|
2025
Q3 | $2.17M | Buy |
21,997
+1,079
| +5% | +$107K | 0.01% | 633 |
|
|
2025
Q2 | $1.91M | Buy |
20,918
+2,487
| +13% | +$240K | 0.01% | 615 |
|
|
2025
Q1 | $2.09M | Sell |
18,431
-4,149
| -18% | -$444K | 0.01% | 569 |
|
|
2024
Q4 | $2.39M | Buy |
22,580
+1,925
| +9% | +$207K | 0.01% | 595 |
|
|
2024
Q3 | $2.23M | Sell |
20,655
-1,721
| -8% | -$188K | 0.01% | 601 |
|
|
2024
Q2 | $2.43M | Buy |
22,376
+794
| +4% | +$93.6K | 0.01% | 590 |
|
|
2024
Q1 | $2.85M | Buy |
21,582
+305
| +1% | +$38.1K | 0.01% | 597 |
|
|
2023
Q4 | $2.59M | Sell |
21,277
-527
| -2% | -$58.8K | 0.01% | 608 |
|
|
2023
Q3 | $2.45M | Buy |
21,804
+1,570
| +8% | +$199K | 0.01% | 556 |
|
|
2023
Q2 | $2.95M | Buy |
20,234
+1,458
| +8% | +$198K | 0.02% | 533 |
|
|
2023
Q1 | $2.43M | Buy |
18,776
+738
| +4% | +$92.7K | 0.02% | 550 |
|
|
2022
Q4 | $2.3M | Buy |
18,038
+6,800
| +61% | +$789K | 0.02% | 536 |
|
|
2022
Q3 | $1.18M | Buy |
11,238
+6,153
| +121% | +$675K | 0.01% | 623 |
|
|
2022
Q2 | $534K | Sell |
5,085
-1,300
| -20% | -$154K | ﹤0.01% | 791 |
|
|
2022
Q1 | $817K | Sell |
6,385
-847
| -12% | -$102K | ﹤0.01% | 824 |
|
|
2021
Q4 | $892K | Buy |
7,232
+373
| +5% | +$48.8K | ﹤0.01% | 924 |
|
|
2021
Q3 | $975K | Buy |
6,859
+2,415
| +54% | +$355K | 0.01% | 838 |
|
|
2021
Q2 | $694K | Buy |
4,444
+404
| +10% | +$65.4K | ﹤0.01% | 1002 |
|
|
2021
Q1 | $628K | Buy |
4,040
+520
| +15% | +$80.5K | ﹤0.01% | 925 |
|
|
2020
Q4 | $527K | Sell |
3,520
-329
| -9% | -$46.5K | 0.01% | 671 |
|
|
2020
Q3 | $509K | Sell |
3,849
-942
| -20% | -$123K | 0.01% | 690 |
|
|
2020
Q2 | $555K | Buy |
+4,791
| New | +$552K | 0.01% | 689 |
|
|
2020
Q1 | – | Sell |
-5,721
| Closed | -$831K | – | 820 |
|
|
2019
Q4 | $831K | Buy |
+5,721
| New | +$790K | 0.01% | 589 |
|
|
2019
Q2 | – | Sell |
-4,809
| Closed | -$596K | – | 858 |
|
|
2019
Q1 | $596K | Buy |
+4,809
| New | +$546K | 0.01% | 633 |
|
|
2015
Q4 | – | Sell |
-4,835
| Closed | -$441K | – | 599 |
|
|
2015
Q3 | $441K | Buy |
+4,835
| New | +$485K | 0.03% | 407 |
|
Other funds holding ZBH
Rafferty Asset Management's ZBH Position: Q2 2026 in Review
Rafferty Asset Management increased its Zimmer Biomet (ZBH) stake by 39% in Q2 2026, buying an estimated $525K and bringing the position to 21,296 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #661.
Rafferty Asset Management first reported a position in ZBH in Q3 2015 and has held it in 28 quarters since. The position peaked at $2.95M in Q2 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Rafferty Asset Management held 21,296 shares of Zimmer Biomet worth $1.83M as of Q2 2026.
- Rafferty Asset Management bought 5,985 Zimmer Biomet shares in Q2 2026, an estimated $525K.
- Zimmer Biomet made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #661 holding.
- Rafferty Asset Management first reported a position in Zimmer Biomet in Q3 2015 and has held it in 28 quarters since.
- Rafferty Asset Management's Zimmer Biomet position peaked at $2.95M in Q2 2023.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.